SCHEMBL5487747

SCHEMBL5487747

COc1ccc(N(c2ccc(/C=C/c3ccccc3)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.78
RELA Q04206 9/20 0.58
TRPM8 Q7Z2W7 1/20 0.54
NFE2L2 Q16236 4/20 0.53
ESR1 P03372 2/20 0.53
ABL1 P00519 1/20 0.53
TTR P02766 1/20 0.53
CYP1A1 P04798 1/20 0.53
CYP1A2 P05177 1/20 0.53
ABCB1 P08183 1/20 0.53
ALOX5 P09917 1/20 0.53
BCR P11274 1/20 0.53
CYP19A1 P11511 1/20 0.53
NQO2 P16083 1/20 0.53
PTGS2 P35354 1/20 0.53
CYP1B1 Q16678 1/20 0.53
TUBB4A P04350 1/20 0.53
TUBB P07437 1/20 0.53
TUBA3C P0DPH7 1/20 0.53
AHR P35869 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5487752 1.00 TRPA1 (0.78) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL5493476 0.98 TRPA1 (0.75) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL5493474 0.98 TRPA1 (0.75) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL16492030 0.96 TRPA1 (0.71) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL8943882 0.96 TRPA1 (0.71) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL8943877 0.96 TRPA1 (0.71) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL7873582 0.96 TRPA1 (0.71) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL6819748 0.96 TRPA1 (0.71) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL4402914 0.96 TRPA1 (0.71) TRPA1RELATRPM8NFE2L2ESR1
SCHEMBL7821780 0.96 TRPA1 (0.71) TRPA1RELATRPM8NFE2L2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276627-B2 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-10-02 US disclosed
US-20060224017-A1 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060224017-A1 One pot sequential reactions and novel products produced thereby PNMT, CYP1A1, TERT TRPA1 1677/4885RELA 1503/4885TRPM8 2842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.